Synaptic vesicle protein 2A (SV2A) has become an attractive target of investigation due to its possible role in the pathophysiology of epilepsy. This protein is expressed ubiquitously in all nerve terminals independently of their neurotransmitter content. A decrease in SV2A levels has been reported in patients with refractory epilepsy and...